Gastroenterologia y hepatologia最新文献

筛选
英文 中文
Food-related quality of life in inflammatory bowel disease: Validity and reliability of the Brazilian version of the FR-QoL-29-Portuguese-Brazil. 炎症性肠病的食物相关生活质量:巴西版fr - qol -29-葡萄牙-巴西的效度和可靠性
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-31 DOI: 10.1016/j.gastrohep.2026.502754
Isadora Sayuri Macedo Tuma, Maria Paula Carlin Cambi, Sara Fernanda de Oliveira Dominski, Patrícia Ignácio, Daniéla Oliveira Magro, Kevin Whelan, Paulo Gustavo Kotze
{"title":"Food-related quality of life in inflammatory bowel disease: Validity and reliability of the Brazilian version of the FR-QoL-29-Portuguese-Brazil.","authors":"Isadora Sayuri Macedo Tuma, Maria Paula Carlin Cambi, Sara Fernanda de Oliveira Dominski, Patrícia Ignácio, Daniéla Oliveira Magro, Kevin Whelan, Paulo Gustavo Kotze","doi":"10.1016/j.gastrohep.2026.502754","DOIUrl":"10.1016/j.gastrohep.2026.502754","url":null,"abstract":"<p><strong>Objective: </strong>Our aim was to (i) undertake a comprehensive translation of the FR-QoL-29 instrument to Brazilian-Portuguese; and (ii) evaluate its validity and reliability in patients with IBD in Brazil.</p><p><strong>Materials and methods: </strong>The FR-QoL-29 underwent forward and backward translation to Brazilian-Portuguese. A cross-sectional study was conducted in patients with IBD either in remission or with active disease at a tertiary referral center in Brazil. Clinical and demographic characteristics, Montreal classification and anthropometric measurements were collected. Data were compared with controls without any gastrointestinal disease.</p><p><strong>Results: </strong>A total of 203 consecutive patients were included, of whom 173 had IBD and 30 were controls. Cronbach's α was 0.93 for IBD patients without previous IBD-related surgery, 0.93 for IBD patients with previous intestinal surgery, and 0.80 for the control group. Using the Kaiser-Meyer-Olkin (KMO) test to assess sample adequacy, the result was 0.85 for IBD patients without previous surgery (p<0.001) and 0.73 for those with previous IBD-related operations (p<0.001).</p><p><strong>Conclusion: </strong>The FR-QoL-29-Portuguese-Brazil is a valid and reliable tool for use in this language and in this specific population to measure the important factor of food-related quality of life.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502754"},"PeriodicalIF":1.9,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147616024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ischemic gastropathy: An uncommon manifestation of systemic atherosclerosis. 缺血性胃病:系统性动脉粥样硬化的一种罕见表现。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-30 DOI: 10.1016/j.gastrohep.2026.502756
Marta Sánchez Tripiana, Marta Fernández Carrasco, Sara Sánchez Moreno, Carmelo Diéguez Castillo
{"title":"Ischemic gastropathy: An uncommon manifestation of systemic atherosclerosis.","authors":"Marta Sánchez Tripiana, Marta Fernández Carrasco, Sara Sánchez Moreno, Carmelo Diéguez Castillo","doi":"10.1016/j.gastrohep.2026.502756","DOIUrl":"10.1016/j.gastrohep.2026.502756","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502756"},"PeriodicalIF":1.9,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147591758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AN ELEPHANT IN THE AUDITORIUM: EVIDENCE AND NORMATIVITY IN SECOND-LINE TREATMENT OF PRIMARY BILIAR CHOLANGITIS. 观众席上的大象:原发性胆道胆管炎二线治疗的证据和规范性。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-23 DOI: 10.1016/j.gastrohep.2026.502720
Mario Romero-Cristóbal
{"title":"AN ELEPHANT IN THE AUDITORIUM: EVIDENCE AND NORMATIVITY IN SECOND-LINE TREATMENT OF PRIMARY BILIAR CHOLANGITIS.","authors":"Mario Romero-Cristóbal","doi":"10.1016/j.gastrohep.2026.502720","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502720","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502720"},"PeriodicalIF":1.9,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional cure of chronic hepatitis B: the friendly face of allogenic hematopoietic stem cell transplantation. 慢性乙型肝炎的功能性治愈:同种异体造血干细胞移植的友好面孔。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-23 DOI: 10.1016/j.gastrohep.2026.502721
Blanca Mesonero, Joud Zanabili, Elena Granda, Mercedes Rodríguez, Manuel Rodríguez
{"title":"Functional cure of chronic hepatitis B: the friendly face of allogenic hematopoietic stem cell transplantation.","authors":"Blanca Mesonero, Joud Zanabili, Elena Granda, Mercedes Rodríguez, Manuel Rodríguez","doi":"10.1016/j.gastrohep.2026.502721","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502721","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502721"},"PeriodicalIF":1.9,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term effectiveness and safety of colonoscopy-guided Fecal Microbiota Transplantation in recurrent Clostridiodes difficile infection: a prospective case series. 结肠镜引导下粪便菌群移植治疗复发性艰难梭菌感染的长期有效性和安全性:前瞻性病例系列。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-22 DOI: 10.1016/j.gastrohep.2026.502719
A Celis, R Quera, P Núñez, C von Muhlenbrock, R Espinoza, A Concha, C Mendoza, F Marcet, D Araya, J Fuentes, F Riesco, P Correa
{"title":"Long-term effectiveness and safety of colonoscopy-guided Fecal Microbiota Transplantation in recurrent Clostridiodes difficile infection: a prospective case series.","authors":"A Celis, R Quera, P Núñez, C von Muhlenbrock, R Espinoza, A Concha, C Mendoza, F Marcet, D Araya, J Fuentes, F Riesco, P Correa","doi":"10.1016/j.gastrohep.2026.502719","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502719","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502719"},"PeriodicalIF":1.9,"publicationDate":"2026-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in Spain. 西班牙慢性乙型肝炎病毒和丁型肝炎病毒感染的诊断、管理和治疗共识文件
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-11 DOI: 10.1016/j.gastrohep.2026.502717
Sabela Lens, Federico García, Juanjo Mascort, Marta Casado, Carolina Freyre, Alicia Lázaro, Gema Muñoz, Cristina Molera, Javier García-Samaniego, María Buti
{"title":"Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in Spain.","authors":"Sabela Lens, Federico García, Juanjo Mascort, Marta Casado, Carolina Freyre, Alicia Lázaro, Gema Muñoz, Cristina Molera, Javier García-Samaniego, María Buti","doi":"10.1016/j.gastrohep.2026.502717","DOIUrl":"10.1016/j.gastrohep.2026.502717","url":null,"abstract":"<p><p>Chronic infection by hepatitis B virus (HBV) and hepatitis D virus (HDV) continues to pose a major public health challenge in Spain due to its high morbidity and mortality and the risk of progression to cirrhosis and hepatocellular carcinoma. Although effective tools exist for the control of hepatitis B and recent therapeutic advances have been made for hepatitis D, significant inequalities persist in early diagnosis, access to treatment, and appropriate patient follow-up. This consensus document has been jointly developed by the Spanish Association for the Study of the Liver (AEEH), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)-through its Viral Hepatitis Study Group (GEHEP)-the Spanish Society of Digestive Pathology (SEPD), the Spanish Society of Family and Community Medicine (semFYC), the Spanish Society of Hospital Pharmacy (SEFH), the Alliance for the Elimination of Viral Hepatitis in Spain (AEHVE), and the Spanish Society of Paediatric Gastroenterology, Hepatology and Nutrition (SEGHNP). The objective is to provide updated and consensus-based recommendations on the diagnosis, management, and treatment of chronic HBV and HDV infection, from a multidisciplinary perspective and adapted to real-world clinical practice. The document addresses screening and diagnostic strategies, criteria for assessing liver fibrosis, indications for antiviral treatment, specific management of hepatitis D, and the role of coordination between primary care and hospital care. Likewise, it emphasizes the need to implement strategies to advance toward the goals of viral hepatitis elimination.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502717"},"PeriodicalIF":1.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147456673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fournier's gangrene in a patient with hepatocellular carcinoma receiving systemic therapy with atezolizumab plus bevacizumab. 接受阿特唑单抗联合贝伐单抗系统治疗的肝细胞癌患者的富尼耶坏疽
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-11 DOI: 10.1016/j.gastrohep.2026.502718
Elena Granda Villanueva, Blanca Mesonero de la Cruz, Jaime Álvarez Grau, Andrés Curiel Elizondo, Lorena Carballo Folgoso, Andrés Castaño García
{"title":"Fournier's gangrene in a patient with hepatocellular carcinoma receiving systemic therapy with atezolizumab plus bevacizumab.","authors":"Elena Granda Villanueva, Blanca Mesonero de la Cruz, Jaime Álvarez Grau, Andrés Curiel Elizondo, Lorena Carballo Folgoso, Andrés Castaño García","doi":"10.1016/j.gastrohep.2026.502718","DOIUrl":"10.1016/j.gastrohep.2026.502718","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502718"},"PeriodicalIF":1.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147456638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving quality in IBD - Evaluation of corticosteroid excess prescription trends and its predictive role in disease-related outcomes. 改善IBD的质量——皮质类固醇过量处方趋势的评估及其在疾病相关结局中的预测作用。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-11 DOI: 10.1016/j.gastrohep.2026.502716
José Damasceno, Tânia Carvalho, Bruno Arroja, João Soares, Sofia Mendes, Bruno Gonçalves, Ana Rebelo, Raquel Gonçalves, Tiago Leal
{"title":"Improving quality in IBD - Evaluation of corticosteroid excess prescription trends and its predictive role in disease-related outcomes.","authors":"José Damasceno, Tânia Carvalho, Bruno Arroja, João Soares, Sofia Mendes, Bruno Gonçalves, Ana Rebelo, Raquel Gonçalves, Tiago Leal","doi":"10.1016/j.gastrohep.2026.502716","DOIUrl":"10.1016/j.gastrohep.2026.502716","url":null,"abstract":"<p><strong>Objective: </strong>Corticosteroids (CS) are effective in the induction of remission in inflammatory bowel disease (IBD), but have an unfavorable side effect profile. A CS sparing strategy is frequently recommended, but its consequences in IBD outcomes have been scarcely studied. Our primary aim was to evaluate current CS use and excess in IBD patients, comparing them with a historic cohort. Our secondary aims were to identify predictors of CS excess and compare outcomes (surgery, hospitalization, new CS cycle, structural damage and a composite outcome) at 12 months between three prescription groups (no CS use, standard CS use, and excess CS use).</p><p><strong>Patients and methods: </strong>A retrospective study, including adult IBD outpatients from two trimesters (one in 2014 and one in 2023). CS prescription trends were compared between groups. The latter was used to identify predictors of CS excess and compare outcomes between prescription groups.</p><p><strong>Results: </strong>A total of 1131 outpatients with IBD were included, 374 in 2014 and 757 in 2023. CS use was 3.2 times lower in 2023 (6.5% vs. 20.6%, p<0.001), and CS excess was 5.5 times lower (12.0% vs. 2.2%, p<0.001). Crohn's disease, extraintestinal manifestations, absence of medication, clinical activity and hospitalization in the previous 12 months were independent predictors of CS excess. CS excess prescription was an independent predictor of hospitalization (HR 15.225, 95% CI 2.189-105.913, p=0.006), new CS cycle (HR 38.392, 95% CI 13.866-106.299, p<0.001) and the composite outcome (HR 32.253, 95% CI 13.260-78.452, p<0.001) at 12 months.</p><p><strong>Conclusions: </strong>CS prescription rate has significantly decreased in our center. CS excess was associated with negative outcomes, namely hospitalization and new CS cycles. Improving quality-of-care in IBD should focus on avoiding excess CS prescription.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502716"},"PeriodicalIF":1.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147456670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive vs. moderate fluid resuscitation in acute pancreatitis: A systematic review and meta-analysis. 急性胰腺炎强化与中度液体复苏:系统回顾和荟萃分析
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-10 DOI: 10.1016/j.gastrohep.2026.502715
Naomi Salcedo-Campos, Jose Caballero-Alvarado, Victor Lau-Torres, Carlos Zavaleta-Corvera
{"title":"Intensive vs. moderate fluid resuscitation in acute pancreatitis: A systematic review and meta-analysis.","authors":"Naomi Salcedo-Campos, Jose Caballero-Alvarado, Victor Lau-Torres, Carlos Zavaleta-Corvera","doi":"10.1016/j.gastrohep.2026.502715","DOIUrl":"10.1016/j.gastrohep.2026.502715","url":null,"abstract":"<p><strong>Objective: </strong>Intravenous fluid resuscitation is central to the early management of acute pancreatitis (AP), but the optimal intensity remains uncertain. This systematic review and meta-analysis compared intensive or aggressive vs. moderate fluid resuscitation in adults with AP.</p><p><strong>Patients and methods: </strong>This systematic review and meta-analysis followed PRISMA 2020 and was registered in PROSPERO (CRD42024626152). PubMed, Scopus, Web of Science, and Embase were searched from inception to February 15, 2024 for Randomized Controlled Trials (RCT) enrolling adults with acute pancreatitis and comparing intensive/aggressive vs. moderate fluid resuscitation. The primary outcome was in-hospital mortality; secondary outcomes were length of hospital stay, persistence of systemic inflammatory response syndrome (SIRS), fluid-overload complications, and early clinical improvement (≤36h). Risk of bias was assessed with RoB 2.0. Pooled relative risks (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using fixed- or random-effects models according to heterogeneity (I<sup>2</sup>). Analyses were performed in RevMan 5.4.1.</p><p><strong>Results: </strong>Seven RCTs were included. IFR was associated with higher mortality than MFR (RR 2.60; 95% CI 1.48-4.57; I<sup>2</sup>=0%). IFR did not reduce LOS (MD 1.21 days; 95% CI 0.72-1.69; I<sup>2</sup>=65%) or SIRS persistence (RR 0.87; 95% CI 0.50-1.52; I<sup>2</sup>=26%). Fluid-overload complications were more frequent with IFR (RR 3.34; 95% CI 1.60-6.98; I<sup>2</sup>=0%). Early clinical improvement did not differ (RR 1.20; 95% CI 0.63-2.29; I<sup>2</sup>=72%). Risk of bias was generally low.</p><p><strong>Conclusions: </strong>Across randomized evidence, intensive hydration offers no clinical benefit over moderate regimens and is associated with higher mortality and greater risk of fluid overload. Findings support moderate, goal-directed, individualized fluid therapy in acute pancreatitis and highlight the need for large multicenter RCTs to refine fluid targets and monitoring endpoints.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502715"},"PeriodicalIF":1.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147443379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraneoplasic cholestatic hepatitis secondary to Hodgkin lymphoma treated with MARS therapy and brentuximab vedotin. 用MARS和brentuximab vedotin治疗的结肠炎副瘤继发性霍奇金淋巴瘤。
IF 1.9 4区 医学
Gastroenterologia y hepatologia Pub Date : 2026-03-06 DOI: 10.1016/j.gastrohep.2026.502713
Ana Tirado Escuder, María Paz Palacios Rosales, Pablo Bellot García, Cayetano Fabián Miralles Maciá
{"title":"Paraneoplasic cholestatic hepatitis secondary to Hodgkin lymphoma treated with MARS therapy and brentuximab vedotin.","authors":"Ana Tirado Escuder, María Paz Palacios Rosales, Pablo Bellot García, Cayetano Fabián Miralles Maciá","doi":"10.1016/j.gastrohep.2026.502713","DOIUrl":"10.1016/j.gastrohep.2026.502713","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502713"},"PeriodicalIF":1.9,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147377119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书